ReviewCNS drugs2005
US FDA-approved disease-modifying treatments for multiple sclerosis: review of adverse effect profiles.
Steven L Galetta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ReviewCNS drugs2005
Steven L Galetta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.